https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL support programmes will exceed €1.5 million in 2026

20 de February de 2026

The call, published in the Official Gazette of Cantabria (BOC) on February 18, 2026, promotes talent recruitment, innovation, internationalization, and patient-based studies. The Marqués de Valdecilla Research Institute (IDIVAL) has launched eight biomedical research promotion programmes under the 2026 call of the PLADIBIO programme, published in the Official Gazette of Cantabria (BOC) on February 18 […]

Read more →

IDIVAL awarded “Best Healthcare Entity” at the 2025 New Medical Economics Awards

11 de November de 2025

The Valdecilla Health Research Institute (IDIVAL) has been recognized as Best Healthcare Entity at the 2025 New Medical Economics Awards, which each year highlight excellence, innovation, and the healthcare sector’s commitment to society. Following an evaluation process that combined the scrutiny of its Editorial Board and the participation of its readers, New Medical Economics magazine […]

Read more →

IMPaCT Cohort: a large study to improve the health of the Spanish population

16 de May de 2024

Cohorte IMPaCT is an ambitious health study of the Instituto de Salud Carlos III coordinated by the Centro de Investigación Biomédica en Red (CIBER) that aims to monitor the health of 200,000 people living in Spain over 20 years. Cohorte IMPaCT is being developed thanks to the participation of all the Autonomous Communities. It will […]

Read more →